Cited by 77TGF-β signaling in diseasesConnective Tissue Growth Factor ResearchAngiogenesis and VEGF in Cancer

Role of secreted modular calcium-binding protein 1 (SMOC1) in transforming growth factor β signalling and angiogenesis

Awwad, Khader, Hu, Jiong, Shi, Lei, Mangels, Nicole, Abdel Malik, Randa, Zippel, Nina, Fisslthaler, Beate, Eble, Johannes A. +3 more·2015·Cardiovascular Research

Abstract

AIMS: Secreted modular calcium-binding protein 1 (SMOC1) is a matricellular protein that potentially interferes with growth factor receptor signalling. The aim of this study was to determine how its expression is regulated in endothelial cells and its role in the regulation of endothelial cell function. METHODS AND RESULTS: SMOC1 was expressed by native murine endothelial cells as well as by cultured human, porcine, and murine endothelial cells. SMOC1 expression in cultured cells was increased by hypoxia via the down-regulation of miR-223, and SMOC1 expression was increased in lungs from miR-223-deficient mice. Silencing SMOC1 (small interfering RNA) attenuated endothelial cell proliferation, migration, and sprouting in in vitro angiogenesis assays. Similarly endothelial cell sprouting from aortic rings ex vivo as well as postnatal retinal angiogenesis in vivo was attenuated in SMOC1(+/-) mice. In endothelial cells, transforming growth factor (TGF)-β signalling via activin-like kinase (ALK) 5 leads to quiescence, whereas TGF-β signalling via ALK1 results in endothelial cell activation. SMOC1 acted as a negative regulator of ALK5/SMAD2 signalling, resulting in altered α2 integrin levels. Mechanistically, SMOC1 associated (immunohistochemistry, proximity ligation assay, and co-immunoprecipitation) with endoglin; an endothelium-specific type III auxiliary receptor for the TGF-β super family and the effects of SMOC1 down-regulation on SMAD2 phosphorylation were abolished by the down-regulation of endoglin. CONCLUSION: These results indicate that SMOC1 is an ALK5 antagonist produced by endothelial cells that tips TGF-β signalling towards ALK1 activation, thus promoting endothelial cell proliferation and angiogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cvr/cvv098

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SMOC1 belongs to a family of matricellular proteins including SPARC, SMOC2, and testican-1.

    “SMOC1 belongs to a family of matricellular proteins including secreted protein acidic and rich in cysteine (SPARC), SMOC2, and testican-1 [267].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Awwad, K., Hu, J., Shi, L., Mangels, N., Abdel Malik, R., Zippel, N., Fisslthaler, B., Eble, J. A., Pfeilschifter, J., Popp, R., & Fleming, I.
Affiliations
  • Goethe University Frankfurt (DE)
  • University of Münster (DE)
  • University Hospital Frankfurt (DE)
Corresponding author
Fleming, Ingrid
Venue
Cardiovascular Research
Published
2015-03-06
Volume
106
Issue
2
Pages
284-294
ISSN
  • 0008-6363 (ISSN-L)
  • 1755-3245
OpenAlex
W1982494697
Cited by
77
References
56
Citations by year
2026: 5 · 2025: 8 · 2024: 7 · 2023: 4 · 2022: 10 · 2021: 13 · 2020: 10 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 2 · 2015: 1
FWCI
2.31
Type
journal article
Language
en
Open access
closed
Locations
  • Cardiovascular Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Deutsche Forschungsgemeinschaft (SFB 1039/A6, SFB-1039, Exzellenzcluster 147, 834/A9, SFB,834)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
SMOC1, matricellular proteins, TGF-beta signaling, angiogenesis, endothelial cells, ALK5, ALK1, CD105, Smad2 phosphorylation, miR-223, hypoxia, endothelial cell proliferation, endothelial cell migration, retinal angiogenesis, integrin alpha2
MeSH terms
Animals, Endothelium, Vascular, Mice, Inbred C57BL, Mice, Transgenic, Swine, Signal Transduction, Osteonectin, Transforming Growth Factor beta, Receptors, Transforming Growth Factor beta, Neovascularization, Physiologic, Activin Receptors, Type I, Activin Receptors, Type II, Endothelial Cells, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review